KEY FEATURES
Full Name | Estrogen Receptor Alpha |
---|---|
Synonym | ER-A1; ER; ESR; ESR1; ESRA; NR3A1; NR3-A1; Estrogen Receptor 1; Nuclear Receptor Subfamily 3,Group A,Member 1 |
Assay Type | Sandwich |
Reactivity | Human |
Range | 0.62-40ng/mL |
Sensitivity | 0.28ng/mL |
Sample Type | Serum,plasma and other biological fluids |
Sample Volume | 100μL |
Detection Wavelength | OD450 |
Transportation Temperature | 2-8°C |
Specificity | The kit detected Human ERa in the samples and no significant cross-species reactions were found |
Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human ERa. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human ERa and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human ERa, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human ERa. You can calculate the concentration of Human ERa in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
Components | Specifications | Storage and Notes |
---|---|---|
Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human ERa ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
Intra-assay Precision | Inter-assay Precision | |||||
---|---|---|---|---|---|---|
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (ng/mL) | 2.13 | 3.71 | 18.49 | 2 | 3.41 | 18.76 |
Standard deviation | 0.14 | 0.2 | 0.71 | 0.11 | 0.17 | 0.65 |
CV(%) | 6.37 | 5.51 | 3.82 | 5.71 | 4.95 | 3.48 |
RECOVERY
The recovery of Human ERa spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
Sample Type | Range (%) | Average Recovery (%) |
---|---|---|
Serum(n=8) | 96-108 | 101 |
EDTA plasma (n=8) | 93-108 | 99 |
Cell culture media (n=8) | 92-104 | 97 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human ERa in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with ER ELISA Kits
BRCA1 ELISA Kit | publications with ER and BRCA1 |
CCND1 ELISA Kit | publications with ER and CCND1 |
SP1 ELISA Kit | publications with ER and SP1 |
SRC ELISA Kit | publications with ER and SRC |
HDAC1 ELISA Kit | publications with ER and HDAC1 |
NRIP1 ELISA Kit | publications with ER and NRIP1 |
NCOA3 ELISA Kit | publications with ER and NCOA3 |
NCOA1 ELISA Kit | publications with ER and NCOA1 |
NCOA2 ELISA Kit | publications with ER and NCOA2 |
EP300 ELISA Kit | publications with ER and EP300 |
Pathways associated with ER ELISA Kit
Endocrine And Other Factor-regulated Calcium Reabsorption Pathway | Endocrine And Other Factor-regulated Calcium Reabsorption Pathway |
Estrogen Signaling Pathway | Estrogen Signaling Pathway |
FOXA1 Transcription Factor Network Pathway | FOXA1 Transcription Factor Network Pathway |
FOXM1 Transcription Factor Network Pathway | FOXM1 Transcription Factor Network Pathway |
Gene Expression Pathway | Gene Expression Pathway |
Generic Transcription Pathway | Generic Transcription Pathway |
Integrated Breast Cancer Pathway | Integrated Breast Cancer Pathway |
Diseases associated with ER ELISA Kit
Breast Neoplasms | publications with ER and Breast Neoplasms |
Carcinoma | publications with ER and Carcinoma |
Female Urogenital Diseases | publications with ER and Female Urogenital Diseases |
Adenocarcinoma | publications with ER and Adenocarcinoma |
Disease Progression | publications with ER and Disease Progression |
Bone Diseases, Metabolic | publications with ER and Bone Diseases, Metabolic |
Obesity | publications with ER and Obesity |
Neoplasm Metastasis | publications with ER and Neoplasm Metastasis |
Infertility, Female | publications with ER and Infertility, Female |
Prostatic Neoplasms | publications with ER and Prostatic Neoplasms |
Organs/Tissues associated with ER ELISA Kit
Brain | publications with ER and Brain |
Ovary | publications with ER and Ovary |
Uterus | publications with ER and Uterus |
Testis | publications with ER and Testis |
Heart | publications with ER and Heart |
Prostate | publications with ER and Prostate |
Muscle | publications with ER and Muscle |
Lung | publications with ER and Lung |
Connective Tissue | publications with ER and Connective Tissue |
Mammary Gland | publications with ER and Mammary Gland |